UNI-EN 66:Current report re insiders transactions -66-Donev
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 66 | / | 2017 | |||||||
| Date of issue: | 2017-09-05 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report re insiders transactions -66-Donev | |||||||||||
| Official market - legal basis | |||||||||||
| art. 19. 3 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| SOPHARMA AD (the “Company”) announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that he, executed the following transactions related to shares in the Company: Date and time(UTC) of the transaction Operation Number of shares Unit price (BGN) 01.09.2017 Buy 500 4.6050 01.09.2017 Buy 5 000 4.6000 01.09.2017 Buy 2 320 4.6000 01.09.2017 Buy 85 4.6500 01.09.2017 Buy 1 915 4.6500 01.09.2017 Buy 2 680 4.6000 01.09.2017 Buy 100 4.7450 01.09.2017 Buy 170 4.7490 01.09.2017 Buy 140 4.7500 01.09.2017 Buy 185 4.7940 01.09.2017 Buy 100 4.7950 01.09.2017 Buy 700 4.7950 01.09.2017 Buy 165 4.7970 01.09.2017 Buy 1 000 4.7980 01.09.2017 Buy 300 4.8000 01.09.2017 Buy 2 961 4.8000 01.09.2017 Buy 574 4.8000 01.09.2017 Buy 160 4.7990 01.09.2017 Buy 1 4.8000 01.09.2017 Buy 1 839 4.8000 01.09.2017 Buy 1 000 4.8050 01.09.2017 Buy 85 4.8000 01.09.2017 Buy 915 4.8000 01.09.2017 Buy 190 4.7500 01.09.2017 Buy 20 4.7400 01.09.2017 Buy 495 4.7400 01.09.2017 Buy 485 4.7400 01.09.2017 Buy 100 4.7000 01.09.2017 Buy 250 4.7190 01.09.2017 Buy 170 4.7440 01.09.2017 Buy 500 4.7450 01.09.2017 Buy 340 4.7790 01.09.2017 Buy 233 4.7800 01.09.2017 Buy 170 4.7870 01.09.2017 Buy 180 4.7890 01.09.2017 Buy 3 000 4.7900 01.09.2017 Buy 407 4.7900 01.09.2017 Buy 3 000 4.7200 01.09.2017 Buy 500 4.7900 01.09.2017 Buy 300 4.7880 01.09.2017 Buy 25 4.7880 01.09.2017 Buy 200 4.7890 01.09.2017 Buy 790 4.7890 01.09.2017 Buy 185 4.7890 01.09.2017 Buy 1 000 4.7500 04.09.2017 Buy 1 000 4.7700 04.09.2017 Buy 2 000 4.7700 04.09.2017 Buy 288 4.7600 04.09.2017 Buy 112 4.7600 04.09.2017 Buy 300 4.7400 04.09.2017 Buy 5 000 4.6500 04.09.2017 Buy 1 000 4.6500 05.09.2017 Buy 300 4.6890 05.09.2017 Buy 300 4.6890 05.09.2017 Buy 300 4.6890 05.09.2017 Buy 300 4.6890 05.09.2017 Buy 500 4.6850 05.09.2017 Buy 434 4.6850 05.09.2017 Buy 500 4.6850 05.09.2017 Buy 800 4.6650 05.09.2017 Buy 200 4.6650 05.09.2017 Buy 700 4.6850 05.09.2017 Buy 300 4.6890 05.09.2017 Buy 300 4.6890 05.09.2017 Buy 100 4.6890 05.09.2017 Buy 300 4.6890 05.09.2017 Buy 300 4.6890 05.09.2017 Buy 200 4.6890 05.09.2017 Buy 31 4.6890 05.09.2017 Buy 269 4.6890 05.09.2017 Buy 400 4.6900 05.09.2017 Buy 700 4.6900 05.09.2017 Buy 585 4.6900 05.09.2017 Buy 40 4.6900 05.09.2017 Buy 271 4.6800 05.09.2017 Buy 735 4.6800 05.09.2017 Buy 1 500 4.6700 05.09.2017 Buy 2 000 4.6650 05.09.2017 Buy 964 4.6400 05.09.2017 Buy 1 000 4.6590 05.09.2017 Buy 500 4.7000 05.09.2017 Buy 230 4.7000 05.09.2017 Buy 770 4.7000 05.09.2017 Buy 66 4.6500 05.09.2017 Buy 270 4.7000 05.09.2017 Buy 230 4.7000 05.09.2017 Buy 3 000 4.7000 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report re insiders transactions -66-Donev.doc Current report re insiders transactions -66-Donev.doc | Current report re insiders transactions -66-Donev | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2017-09-05 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.4 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
